Agena Announces MassARRAY^® Commercial Partnership Agreement With Dian For China Clinical Laboratory Market More

San Diego, CA, July 10, 2018 – Agena Bioscience announced today that it has entered into a commercial partnership agreement with Zhejiang Dian Diagnostics

GenomeWeb 360Dx: Agena Looks to China for Global Expansion of the MassARRAY Platform More

New York, NY (360DX), June 6, 2018 –  For Agena Bioscience CEO Peter Dansky, expanding a diagnostics company means going where the growth is, and for

Agena and Simceredx Announce Strategic Partnership to Develop and Commercialize Companion Diagnostics in China More

San Diego, CA, and Nanjing, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical

Agena Bioscience’s Liquid Biopsy Technology Awarded Horizon 2020 Grant by European Union More

San Diego, CA, November 30, 2017 – Agena Bioscience, a global provider of molecular genetic solutions, today announced it has been selected to participate

Agena Bioscience Bolsters MassARRAY Insights™ Reporting Network by Adding N-of-One More

The collaboration will focus on results interpretation for cancer genomics. San Diego, CA, October 5, 2017– Agena Bioscience, a global provider of molecular

Highly Sensitive Assessment Of Common Somatic Mutations In Pulmonary Non-Small Cell Carcinoma With the MassARRAY^® System More

San Diego, CA, September 27, 2017 – Agena Bioscience today announced a comparative study published in PLOS ONE highlighting the use of its mass spectrometry-based